INFINITY PHARMACEUTICALS Stock Quote

$2.32 arrow  Change: -0.07 %Chge: -2.93% Vol: 77,106
End Of Day Prices
High: 2.44 | Low: 2.27 | Open: 2.44 | Close: 2.32
52 Wk High: 3.83 | 52 Wk Low: 0.85 | Todays Pivot: 2.34
Sector: add stock to watch list

INFI Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Infinity Pharmaceuticals

What Makes Infinity Pharmaceuti (INFI) and Oclaro Inc (OCLR) Different?

The relative volume of the stock is 63.31, while its market cap is $84.26 Million. The RSI oscillates between zero and 100. Infinity Pharmaceuticals Inc. (NASDAQ:INFI) is to make a presentation on a Phase 1/1b clinical study which is evaluating the safety ...


Infinity Pharmaceuticals (INFI) Stock: Gaining On Coming Presentation

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) is having an overwhelmingly strong start to the trading session this morning after the company announced that a presentation surrounding IPI-549 is coming. Of course, the coming clinical data caused excitement ...


20 Nasdaq Stocks Slide in New York this Morning – INFI, IMDZ, HAIR, QURE, MNKD, SNCR, KONA, SORL, VIRT, ESPR

Infinity Pharmaceuticals (NASDAQ: INFI) has hit an intraday price of $2.10 down 22.22 percent on 3,694,466 total traded shares. Immune Design (NASDAQ: IMDZ) has hit an intraday price of $6.55 down 20.12 percent on 2,193,480 total traded shares. Restoration ...


Infinity Pharmaceutical (NASDAQ:INFI) has been upgraded from Market Perform to Outperform in a statement by Wells Fargo earlier today.

Wells Fargo has upgraded Infinity Pharmaceutical (NASDAQ:INFI) from Market Perform to Outperform in a statement released on 10/12/2017. Having a price of $1.67, Infinity Pharmaceutical (NASDAQ:INFI) traded 57.57% higher on the day. With the last close up ...


INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints

Gained 123.35% to close Thursday's (Oct.12) trading at $3.73. News: The Company will be reporting clinical and translational data from monotherapy dose-escalation component of its ongoing phase 1/1b study of IPI-549 in patients with advanced solid tumors ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Infinity Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for INFI to choose from. Visit here to build your stock quote widget »